表达流感血凝素茎部与核蛋白的mRNA疫苗在小鼠和非人灵长类中诱导体液与细胞免疫的特征
研究评估编码1组血凝素茎部、2组核蛋白或两者组合的mRNA疫苗在小鼠中的效力与免疫原性,并在未感染和流感血清阳性非人灵长类中评估免疫原性。HA茎部疫苗诱导强结合抗体但体外中和活性低,核蛋白疫苗诱导强CD4和CD8 T细胞反应;两者组合对两种H1N1株提供更优保护。
要点
- HA茎部mRNA疫苗诱导体液免疫,抗体识别抗原性不同的1组HA蛋白。
- 核蛋白mRNA疫苗在小鼠和非人灵长类中诱导强CD4和CD8 T细胞反应。
- HA茎部和核蛋白mRNA疫苗组合对两种H1N1株提供更优保护。
核心结论
- 编码保守流感抗原(如HA茎部和核蛋白组合)的mRNA疫苗在小鼠和非人灵长类中诱导体液和细胞免疫,并在小鼠中提供对同源和异源流感感染的保护。
研究设计与样本
- 研究评估编码1组血凝素茎部、2组核蛋白或两者组合的mRNA疫苗在小鼠中的效力和免疫原性,并在未感染和流感血清阳性非人灵长类中评估免疫原性。
主要发现
- HA茎部免疫动物产生强抗茎部抗体结合滴度,血清抗体识别抗原性不同的1组HA蛋白。
- 这些抗体在体外显示很小至无中和活性,但在测量抗体依赖性细胞毒性诱导的试验中有活性。
- HA茎部mRNA疫苗接种后HA导向的细胞免疫弱;编码核蛋白的mRNA疫苗免疫后在小鼠和非人灵长类中均检测到强CD4和CD8 T细胞反应。
- HA茎部和核蛋白mRNA疫苗均部分保护小鼠免于致死性流感病毒攻击后的疾病,组合两种抗原时对两种不同H1N1株观察到更优效力。
- 体内T细胞耗竭提示抗核蛋白细胞免疫有助于小鼠模型中的保护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In response to immune pressure, influenza viruses evolve, producing drifted variants capable of escaping immune recognition. One strategy for inducing a broad-spectrum immune response capable of recognizing multiple antigenically diverse strains is to target conserved proteins or protein domains. To that end, we assessed the efficacy and immunogenicity of mRNA vaccines encoding either the conserved stem domain of a group 1 hemagglutinin (HA), a group 2 nucleoprotein (NP), or a combination of the two antigens in mice, as well as evaluated immunogenicity in naïve and influenza seropositive nonhuman primates (NHPs). HA stem-immunized animals developed a robust anti-stem antibody binding titer, and serum antibodies recognized antigenically distinct group 1 HA proteins. These antibodies showed little to no neutralizing activity in vitro but were active in an assay measuring induction of antibody-dependent cellular cytotoxicity. HA-directed cell-mediated immunity was weak following HA stem mRNA vaccination; however, robust CD4 and CD8 T cell responses were detected in both mice and NHPs after immunization with mRNA vaccines encoding NP. Both HA stem and NP mRNA vaccines partially protected mice from morbidity following lethal influenza virus challenge, and superior efficacy against two different H1N1 strains was observed when the antigens were combined. In vivo T cell depletion suggested that anti-NP cell-mediated immunity contributed to protection in the mouse model. Taken together, these data show that mRNA vaccines encoding conserved influenza antigens, like HA stem and NP in combination, induce broadly reactive humoral responses as well as cell-mediated immunity in mice and NHPs, providing protection against homologous and heterologous influenza infection in mice.
引用
- Flynn JA, Weber T, Cejas PJ, et al. Characterization of humoral and cell-mediated immunity induced by mRNA vaccines expressing influenza hemagglutinin stem and nucleoprotein in mice and nonhuman primates. Vaccine. 2022. PMID: 35680500. doi:10.1016/j.vaccine.2022.03.063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。